Form 8-K PALVELLA THERAPEUTICS, For: Dec 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Palvella Therapeutics (PVLA) PT Raised to $190 at Truist Securities
December 15, 2025 2:14 PM ESTTruist Securities analyst Danielle Brill raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $190.00 (from $105.00) while maintaining a Buy rating.
The analyst comments "We incorporated risk adjusted sales for cutaneous venous malformations (CVM) into our PVLA model which raises our PT to $190 (from... More
Palvella Therapeutics (PVLA) PT Raised to $210 at Cantor Fitzgerald
December 15, 2025 10:09 AM ESTCantor Fitzgerald analyst Josh Schimmer raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $210.00 (from $200.00) while maintaining a Overweight rating.
... More


